Global Human Tuberculosis Vaccine Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Human Tuberculosis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Tuberculosis Vaccine.
The Human Tuberculosis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Tuberculosis Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Tuberculosis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Tuberculosis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Tuberculosis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Human Tuberculosis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Tuberculosis Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Tuberculosis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- GlaxoSmithKline
- Merck
- Serum Institute of India
- Valneva
- Archivel Farma
- BIOFABRI (Zendal)
- Japan BCG Laboratory
- GreenSignal Bio Pharma
- AJ Vaccines
- Taj Pharma India
- Biomed Lublin
- Intradermal
- Percutaneous
- Pediatrics
- Adults
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Tuberculosis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Tuberculosis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 ?-METHYLSTYRENE SPECIALTY MONOMER MARKET OVERVIEW
1.1 Product Definition
1.2 ?-Methylstyrene Specialty Monomer Segment by Type
1.2.1 Global ?-Methylstyrene Specialty Monomer Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Purity 99.5% or More
1.2.3 Others
1.3 ?-Methylstyrene Specialty Monomer Segment by Application
1.3.1 Global ?-Methylstyrene Specialty Monomer Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Plasticizer
1.3.3 Resin
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global ?-Methylstyrene Specialty Monomer Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global ?-Methylstyrene Specialty Monomer Production Estimates and Forecasts (2018-2029)
1.4.4 Global ?-Methylstyrene Specialty Monomer Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global ?-Methylstyrene Specialty Monomer Production Market Share by Manufacturers (2018-2023)
2.2 Global ?-Methylstyrene Specialty Monomer Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of ?-Methylstyrene Specialty Monomer, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global ?-Methylstyrene Specialty Monomer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global ?-Methylstyrene Specialty Monomer Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of ?-Methylstyrene Specialty Monomer, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of ?-Methylstyrene Specialty Monomer, Product Offered and Application
2.8 Global Key Manufacturers of ?-Methylstyrene Specialty Monomer, Date of Enter into This Industry
2.9 ?-Methylstyrene Specialty Monomer Market Competitive Situation and Trends
2.9.1 ?-Methylstyrene Specialty Monomer Market Concentration Rate
2.9.2 Global 5 and 10 Largest ?-Methylstyrene Specialty Monomer Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 ?-METHYLSTYRENE SPECIALTY MONOMER PRODUCTION BY REGION
3.1 Global ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global ?-Methylstyrene Specialty Monomer Production Value by Region (2018-2029)
3.2.1 Global ?-Methylstyrene Specialty Monomer Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of ?-Methylstyrene Specialty Monomer by Region (2024-2029)
3.3 Global ?-Methylstyrene Specialty Monomer Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global ?-Methylstyrene Specialty Monomer Production by Region (2018-2029)
3.4.1 Global ?-Methylstyrene Specialty Monomer Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of ?-Methylstyrene Specialty Monomer by Region (2024-2029)
3.5 Global ?-Methylstyrene Specialty Monomer Market Price Analysis by Region (2018-2023)
3.6 Global ?-Methylstyrene Specialty Monomer Production and Value, Year-over-Year Growth
3.6.1 North America ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
3.6.3 China ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
4 ?-METHYLSTYRENE SPECIALTY MONOMER CONSUMPTION BY REGION
4.1 Global ?-Methylstyrene Specialty Monomer Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global ?-Methylstyrene Specialty Monomer Consumption by Region (2018-2029)
4.2.1 Global ?-Methylstyrene Specialty Monomer Consumption by Region (2018-2023)
4.2.2 Global ?-Methylstyrene Specialty Monomer Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America ?-Methylstyrene Specialty Monomer Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America ?-Methylstyrene Specialty Monomer Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe ?-Methylstyrene Specialty Monomer Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe ?-Methylstyrene Specialty Monomer Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific ?-Methylstyrene Specialty Monomer Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific ?-Methylstyrene Specialty Monomer Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa ?-Methylstyrene Specialty Monomer Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa ?-Methylstyrene Specialty Monomer Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 SEGMENT BY TYPE
5.1 Global ?-Methylstyrene Specialty Monomer Production by Type (2018-2029)
5.1.1 Global ?-Methylstyrene Specialty Monomer Production by Type (2018-2023)
5.1.2 Global ?-Methylstyrene Specialty Monomer Production by Type (2024-2029)
5.1.3 Global ?-Methylstyrene Specialty Monomer Production Market Share by Type (2018-2029)
5.2 Global ?-Methylstyrene Specialty Monomer Production Value by Type (2018-2029)
5.2.1 Global ?-Methylstyrene Specialty Monomer Production Value by Type (2018-2023)
5.2.2 Global ?-Methylstyrene Specialty Monomer Production Value by Type (2024-2029)
5.2.3 Global ?-Methylstyrene Specialty Monomer Production Value Market Share by Type (2018-2029)
5.3 Global ?-Methylstyrene Specialty Monomer Price by Type (2018-2029)
6 SEGMENT BY APPLICATION
6.1 Global ?-Methylstyrene Specialty Monomer Production by Application (2018-2029)
6.1.1 Global ?-Methylstyrene Specialty Monomer Production by Application (2018-2023)
6.1.2 Global ?-Methylstyrene Specialty Monomer Production by Application (2024-2029)
6.1.3 Global ?-Methylstyrene Specialty Monomer Production Market Share by Application (2018-2029)
6.2 Global ?-Methylstyrene Specialty Monomer Production Value by Application (2018-2029)
6.2.1 Global ?-Methylstyrene Specialty Monomer Production Value by Application (2018-2023)
6.2.2 Global ?-Methylstyrene Specialty Monomer Production Value by Application (2024-2029)
6.2.3 Global ?-Methylstyrene Specialty Monomer Production Value Market Share by Application (2018-2029)
6.3 Global ?-Methylstyrene Specialty Monomer Price by Application (2018-2029)
7 KEY COMPANIES PROFILED
7.1 Altivia
7.1.1 Altivia ?-Methylstyrene Specialty Monomer Corporation Information
7.1.2 Altivia ?-Methylstyrene Specialty Monomer Product Portfolio
7.1.3 Altivia ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Altivia Main Business and Markets Served
7.1.5 Altivia Recent Developments/Updates
7.2 Cepsa Chemicals
7.2.1 Cepsa Chemicals ?-Methylstyrene Specialty Monomer Corporation Information
7.2.2 Cepsa Chemicals ?-Methylstyrene Specialty Monomer Product Portfolio
7.2.3 Cepsa Chemicals ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Cepsa Chemicals Main Business and Markets Served
7.2.5 Cepsa Chemicals Recent Developments/Updates
7.3 Rosneft
7.3.1 Rosneft ?-Methylstyrene Specialty Monomer Corporation Information
7.3.2 Rosneft ?-Methylstyrene Specialty Monomer Product Portfolio
7.3.3 Rosneft ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Rosneft Main Business and Markets Served
7.3.5 Rosneft Recent Developments/Updates
7.4 Mitsubishi Chemical
7.4.1 Mitsubishi Chemical ?-Methylstyrene Specialty Monomer Corporation Information
7.4.2 Mitsubishi Chemical ?-Methylstyrene Specialty Monomer Product Portfolio
7.4.3 Mitsubishi Chemical ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Mitsubishi Chemical Main Business and Markets Served
7.4.5 Mitsubishi Chemical Recent Developments/Updates
7.5 SI Group
7.5.1 SI Group ?-Methylstyrene Specialty Monomer Corporation Information
7.5.2 SI Group ?-Methylstyrene Specialty Monomer Product Portfolio
7.5.3 SI Group ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.5.4 SI Group Main Business and Markets Served
7.5.5 SI Group Recent Developments/Updates
7.6 Solvay
7.6.1 Solvay ?-Methylstyrene Specialty Monomer Corporation Information
7.6.2 Solvay ?-Methylstyrene Specialty Monomer Product Portfolio
7.6.3 Solvay ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Solvay Main Business and Markets Served
7.6.5 Solvay Recent Developments/Updates
7.7 LG Chem
7.7.1 LG Chem ?-Methylstyrene Specialty Monomer Corporation Information
7.7.2 LG Chem ?-Methylstyrene Specialty Monomer Product Portfolio
7.7.3 LG Chem ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.7.4 LG Chem Main Business and Markets Served
7.7.5 LG Chem Recent Developments/Updates
7.8 Ineos Phenol GmbH
7.8.1 Ineos Phenol GmbH ?-Methylstyrene Specialty Monomer Corporation Information
7.8.2 Ineos Phenol GmbH ?-Methylstyrene Specialty Monomer Product Portfolio
7.8.3 Ineos Phenol GmbH ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Ineos Phenol GmbH Main Business and Markets Served
7.7.5 Ineos Phenol GmbH Recent Developments/Updates
7.9 Prasol Chemicals
7.9.1 Prasol Chemicals ?-Methylstyrene Specialty Monomer Corporation Information
7.9.2 Prasol Chemicals ?-Methylstyrene Specialty Monomer Product Portfolio
7.9.3 Prasol Chemicals ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Prasol Chemicals Main Business and Markets Served
7.9.5 Prasol Chemicals Recent Developments/Updates
7.10 DOMO Chemicals
7.10.1 DOMO Chemicals ?-Methylstyrene Specialty Monomer Corporation Information
7.10.2 DOMO Chemicals ?-Methylstyrene Specialty Monomer Product Portfolio
7.10.3 DOMO Chemicals ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.10.4 DOMO Chemicals Main Business and Markets Served
7.10.5 DOMO Chemicals Recent Developments/Updates
7.11 Jiangsu Evergreen New Material Technology
7.11.1 Jiangsu Evergreen New Material Technology ?-Methylstyrene Specialty Monomer Corporation Information
7.11.2 Jiangsu Evergreen New Material Technology ?-Methylstyrene Specialty Monomer Product Portfolio
7.11.3 Jiangsu Evergreen New Material Technology ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Jiangsu Evergreen New Material Technology Main Business and Markets Served
7.11.5 Jiangsu Evergreen New Material Technology Recent Developments/Updates
8 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
8.1 ?-Methylstyrene Specialty Monomer Industry Chain Analysis
8.2 ?-Methylstyrene Specialty Monomer Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 ?-Methylstyrene Specialty Monomer Production Mode & Process
8.4 ?-Methylstyrene Specialty Monomer Sales and Marketing
8.4.1 ?-Methylstyrene Specialty Monomer Sales Channels
8.4.2 ?-Methylstyrene Specialty Monomer Distributors
8.5 ?-Methylstyrene Specialty Monomer Customers
9 ?-METHYLSTYRENE SPECIALTY MONOMER MARKET DYNAMICS
9.1 ?-Methylstyrene Specialty Monomer Industry Trends
9.2 ?-Methylstyrene Specialty Monomer Market Drivers
9.3 ?-Methylstyrene Specialty Monomer Market Challenges
9.4 ?-Methylstyrene Specialty Monomer Market Restraints
10 RESEARCH FINDING AND CONCLUSION
11 METHODOLOGY AND DATA SOURCE
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 ?-Methylstyrene Specialty Monomer Segment by Type
1.2.1 Global ?-Methylstyrene Specialty Monomer Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Purity 99.5% or More
1.2.3 Others
1.3 ?-Methylstyrene Specialty Monomer Segment by Application
1.3.1 Global ?-Methylstyrene Specialty Monomer Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Plasticizer
1.3.3 Resin
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global ?-Methylstyrene Specialty Monomer Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global ?-Methylstyrene Specialty Monomer Production Estimates and Forecasts (2018-2029)
1.4.4 Global ?-Methylstyrene Specialty Monomer Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global ?-Methylstyrene Specialty Monomer Production Market Share by Manufacturers (2018-2023)
2.2 Global ?-Methylstyrene Specialty Monomer Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of ?-Methylstyrene Specialty Monomer, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global ?-Methylstyrene Specialty Monomer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global ?-Methylstyrene Specialty Monomer Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of ?-Methylstyrene Specialty Monomer, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of ?-Methylstyrene Specialty Monomer, Product Offered and Application
2.8 Global Key Manufacturers of ?-Methylstyrene Specialty Monomer, Date of Enter into This Industry
2.9 ?-Methylstyrene Specialty Monomer Market Competitive Situation and Trends
2.9.1 ?-Methylstyrene Specialty Monomer Market Concentration Rate
2.9.2 Global 5 and 10 Largest ?-Methylstyrene Specialty Monomer Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 ?-METHYLSTYRENE SPECIALTY MONOMER PRODUCTION BY REGION
3.1 Global ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global ?-Methylstyrene Specialty Monomer Production Value by Region (2018-2029)
3.2.1 Global ?-Methylstyrene Specialty Monomer Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of ?-Methylstyrene Specialty Monomer by Region (2024-2029)
3.3 Global ?-Methylstyrene Specialty Monomer Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global ?-Methylstyrene Specialty Monomer Production by Region (2018-2029)
3.4.1 Global ?-Methylstyrene Specialty Monomer Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of ?-Methylstyrene Specialty Monomer by Region (2024-2029)
3.5 Global ?-Methylstyrene Specialty Monomer Market Price Analysis by Region (2018-2023)
3.6 Global ?-Methylstyrene Specialty Monomer Production and Value, Year-over-Year Growth
3.6.1 North America ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
3.6.3 China ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan ?-Methylstyrene Specialty Monomer Production Value Estimates and Forecasts (2018-2029)
4 ?-METHYLSTYRENE SPECIALTY MONOMER CONSUMPTION BY REGION
4.1 Global ?-Methylstyrene Specialty Monomer Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global ?-Methylstyrene Specialty Monomer Consumption by Region (2018-2029)
4.2.1 Global ?-Methylstyrene Specialty Monomer Consumption by Region (2018-2023)
4.2.2 Global ?-Methylstyrene Specialty Monomer Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America ?-Methylstyrene Specialty Monomer Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America ?-Methylstyrene Specialty Monomer Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe ?-Methylstyrene Specialty Monomer Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe ?-Methylstyrene Specialty Monomer Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific ?-Methylstyrene Specialty Monomer Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific ?-Methylstyrene Specialty Monomer Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa ?-Methylstyrene Specialty Monomer Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa ?-Methylstyrene Specialty Monomer Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 SEGMENT BY TYPE
5.1 Global ?-Methylstyrene Specialty Monomer Production by Type (2018-2029)
5.1.1 Global ?-Methylstyrene Specialty Monomer Production by Type (2018-2023)
5.1.2 Global ?-Methylstyrene Specialty Monomer Production by Type (2024-2029)
5.1.3 Global ?-Methylstyrene Specialty Monomer Production Market Share by Type (2018-2029)
5.2 Global ?-Methylstyrene Specialty Monomer Production Value by Type (2018-2029)
5.2.1 Global ?-Methylstyrene Specialty Monomer Production Value by Type (2018-2023)
5.2.2 Global ?-Methylstyrene Specialty Monomer Production Value by Type (2024-2029)
5.2.3 Global ?-Methylstyrene Specialty Monomer Production Value Market Share by Type (2018-2029)
5.3 Global ?-Methylstyrene Specialty Monomer Price by Type (2018-2029)
6 SEGMENT BY APPLICATION
6.1 Global ?-Methylstyrene Specialty Monomer Production by Application (2018-2029)
6.1.1 Global ?-Methylstyrene Specialty Monomer Production by Application (2018-2023)
6.1.2 Global ?-Methylstyrene Specialty Monomer Production by Application (2024-2029)
6.1.3 Global ?-Methylstyrene Specialty Monomer Production Market Share by Application (2018-2029)
6.2 Global ?-Methylstyrene Specialty Monomer Production Value by Application (2018-2029)
6.2.1 Global ?-Methylstyrene Specialty Monomer Production Value by Application (2018-2023)
6.2.2 Global ?-Methylstyrene Specialty Monomer Production Value by Application (2024-2029)
6.2.3 Global ?-Methylstyrene Specialty Monomer Production Value Market Share by Application (2018-2029)
6.3 Global ?-Methylstyrene Specialty Monomer Price by Application (2018-2029)
7 KEY COMPANIES PROFILED
7.1 Altivia
7.1.1 Altivia ?-Methylstyrene Specialty Monomer Corporation Information
7.1.2 Altivia ?-Methylstyrene Specialty Monomer Product Portfolio
7.1.3 Altivia ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Altivia Main Business and Markets Served
7.1.5 Altivia Recent Developments/Updates
7.2 Cepsa Chemicals
7.2.1 Cepsa Chemicals ?-Methylstyrene Specialty Monomer Corporation Information
7.2.2 Cepsa Chemicals ?-Methylstyrene Specialty Monomer Product Portfolio
7.2.3 Cepsa Chemicals ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Cepsa Chemicals Main Business and Markets Served
7.2.5 Cepsa Chemicals Recent Developments/Updates
7.3 Rosneft
7.3.1 Rosneft ?-Methylstyrene Specialty Monomer Corporation Information
7.3.2 Rosneft ?-Methylstyrene Specialty Monomer Product Portfolio
7.3.3 Rosneft ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Rosneft Main Business and Markets Served
7.3.5 Rosneft Recent Developments/Updates
7.4 Mitsubishi Chemical
7.4.1 Mitsubishi Chemical ?-Methylstyrene Specialty Monomer Corporation Information
7.4.2 Mitsubishi Chemical ?-Methylstyrene Specialty Monomer Product Portfolio
7.4.3 Mitsubishi Chemical ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Mitsubishi Chemical Main Business and Markets Served
7.4.5 Mitsubishi Chemical Recent Developments/Updates
7.5 SI Group
7.5.1 SI Group ?-Methylstyrene Specialty Monomer Corporation Information
7.5.2 SI Group ?-Methylstyrene Specialty Monomer Product Portfolio
7.5.3 SI Group ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.5.4 SI Group Main Business and Markets Served
7.5.5 SI Group Recent Developments/Updates
7.6 Solvay
7.6.1 Solvay ?-Methylstyrene Specialty Monomer Corporation Information
7.6.2 Solvay ?-Methylstyrene Specialty Monomer Product Portfolio
7.6.3 Solvay ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Solvay Main Business and Markets Served
7.6.5 Solvay Recent Developments/Updates
7.7 LG Chem
7.7.1 LG Chem ?-Methylstyrene Specialty Monomer Corporation Information
7.7.2 LG Chem ?-Methylstyrene Specialty Monomer Product Portfolio
7.7.3 LG Chem ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.7.4 LG Chem Main Business and Markets Served
7.7.5 LG Chem Recent Developments/Updates
7.8 Ineos Phenol GmbH
7.8.1 Ineos Phenol GmbH ?-Methylstyrene Specialty Monomer Corporation Information
7.8.2 Ineos Phenol GmbH ?-Methylstyrene Specialty Monomer Product Portfolio
7.8.3 Ineos Phenol GmbH ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Ineos Phenol GmbH Main Business and Markets Served
7.7.5 Ineos Phenol GmbH Recent Developments/Updates
7.9 Prasol Chemicals
7.9.1 Prasol Chemicals ?-Methylstyrene Specialty Monomer Corporation Information
7.9.2 Prasol Chemicals ?-Methylstyrene Specialty Monomer Product Portfolio
7.9.3 Prasol Chemicals ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Prasol Chemicals Main Business and Markets Served
7.9.5 Prasol Chemicals Recent Developments/Updates
7.10 DOMO Chemicals
7.10.1 DOMO Chemicals ?-Methylstyrene Specialty Monomer Corporation Information
7.10.2 DOMO Chemicals ?-Methylstyrene Specialty Monomer Product Portfolio
7.10.3 DOMO Chemicals ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.10.4 DOMO Chemicals Main Business and Markets Served
7.10.5 DOMO Chemicals Recent Developments/Updates
7.11 Jiangsu Evergreen New Material Technology
7.11.1 Jiangsu Evergreen New Material Technology ?-Methylstyrene Specialty Monomer Corporation Information
7.11.2 Jiangsu Evergreen New Material Technology ?-Methylstyrene Specialty Monomer Product Portfolio
7.11.3 Jiangsu Evergreen New Material Technology ?-Methylstyrene Specialty Monomer Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Jiangsu Evergreen New Material Technology Main Business and Markets Served
7.11.5 Jiangsu Evergreen New Material Technology Recent Developments/Updates
8 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
8.1 ?-Methylstyrene Specialty Monomer Industry Chain Analysis
8.2 ?-Methylstyrene Specialty Monomer Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 ?-Methylstyrene Specialty Monomer Production Mode & Process
8.4 ?-Methylstyrene Specialty Monomer Sales and Marketing
8.4.1 ?-Methylstyrene Specialty Monomer Sales Channels
8.4.2 ?-Methylstyrene Specialty Monomer Distributors
8.5 ?-Methylstyrene Specialty Monomer Customers
9 ?-METHYLSTYRENE SPECIALTY MONOMER MARKET DYNAMICS
9.1 ?-Methylstyrene Specialty Monomer Industry Trends
9.2 ?-Methylstyrene Specialty Monomer Market Drivers
9.3 ?-Methylstyrene Specialty Monomer Market Challenges
9.4 ?-Methylstyrene Specialty Monomer Market Restraints
10 RESEARCH FINDING AND CONCLUSION
11 METHODOLOGY AND DATA SOURCE
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
LIST OF TABLES
Table 1. Global Human Tuberculosis Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Human Tuberculosis Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Human Tuberculosis Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Tuberculosis Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Tuberculosis Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Tuberculosis Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Tuberculosis Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Human Tuberculosis Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Tuberculosis Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Human Tuberculosis Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Tuberculosis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Tuberculosis Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Tuberculosis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Tuberculosis Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Tuberculosis Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Human Tuberculosis Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Tuberculosis Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Human Tuberculosis Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Tuberculosis Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Human Tuberculosis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Tuberculosis Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Human Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Tuberculosis Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Tuberculosis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Tuberculosis Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Tuberculosis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Tuberculosis Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Tuberculosis Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Tuberculosis Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Tuberculosis Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Tuberculosis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Tuberculosis Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Tuberculosis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Tuberculosis Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Tuberculosis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Tuberculosis Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Human Tuberculosis Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Human Tuberculosis Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Human Tuberculosis Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Tuberculosis Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Human Tuberculosis Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Human Tuberculosis Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Human Tuberculosis Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Human Tuberculosis Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Human Tuberculosis Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Human Tuberculosis Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Human Tuberculosis Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Tuberculosis Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Human Tuberculosis Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Human Tuberculosis Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Human Tuberculosis Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. GlaxoSmithKline Human Tuberculosis Vaccine Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Merck Human Tuberculosis Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Serum Institute of India Human Tuberculosis Vaccine Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. Valneva Corporation Information
Table 86. Valneva Description and Business Overview
Table 87. Valneva Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Valneva Human Tuberculosis Vaccine Product
Table 89. Valneva Recent Developments/Updates
Table 90. Archivel Farma Corporation Information
Table 91. Archivel Farma Description and Business Overview
Table 92. Archivel Farma Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Archivel Farma Human Tuberculosis Vaccine Product
Table 94. Archivel Farma Recent Developments/Updates
Table 95. BIOFABRI (Zendal) Corporation Information
Table 96. BIOFABRI (Zendal) Description and Business Overview
Table 97. BIOFABRI (Zendal) Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. BIOFABRI (Zendal) Human Tuberculosis Vaccine Product
Table 99. BIOFABRI (Zendal) Recent Developments/Updates
Table 100. Japan BCG Laboratory Corporation Information
Table 101. Japan BCG Laboratory Description and Business Overview
Table 102. Japan BCG Laboratory Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Japan BCG Laboratory Human Tuberculosis Vaccine Product
Table 104. Japan BCG Laboratory Recent Developments/Updates
Table 105. GreenSignal Bio Pharma Corporation Information
Table 106. GreenSignal Bio Pharma Description and Business Overview
Table 107. GreenSignal Bio Pharma Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. GreenSignal Bio Pharma Human Tuberculosis Vaccine Product
Table 109. GreenSignal Bio Pharma Recent Developments/Updates
Table 110. AJ Vaccines Corporation Information
Table 111. AJ Vaccines Description and Business Overview
Table 112. AJ Vaccines Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. AJ Vaccines Human Tuberculosis Vaccine Product
Table 114. AJ Vaccines Recent Developments/Updates
Table 115. Taj Pharma India Corporation Information
Table 116. Taj Pharma India Description and Business Overview
Table 117. Taj Pharma India Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Taj Pharma India Human Tuberculosis Vaccine Product
Table 119. Taj Pharma India Recent Developments/Updates
Table 120. Biomed Lublin Corporation Information
Table 121. Biomed Lublin Description and Business Overview
Table 122. Biomed Lublin Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Biomed Lublin Human Tuberculosis Vaccine Product
Table 124. Biomed Lublin Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Human Tuberculosis Vaccine Distributors List
Table 128. Human Tuberculosis Vaccine Customers List
Table 129. Human Tuberculosis Vaccine Market Trends
Table 130. Human Tuberculosis Vaccine Market Drivers
Table 131. Human Tuberculosis Vaccine Market Challenges
Table 132. Human Tuberculosis Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 1. Global Human Tuberculosis Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Human Tuberculosis Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Human Tuberculosis Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Tuberculosis Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Tuberculosis Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Tuberculosis Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Tuberculosis Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Human Tuberculosis Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Tuberculosis Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Human Tuberculosis Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Tuberculosis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Tuberculosis Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Tuberculosis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Tuberculosis Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Tuberculosis Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Human Tuberculosis Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Tuberculosis Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Human Tuberculosis Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Tuberculosis Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Human Tuberculosis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Tuberculosis Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Human Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Tuberculosis Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Tuberculosis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Tuberculosis Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Tuberculosis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Tuberculosis Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Tuberculosis Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Tuberculosis Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Tuberculosis Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Tuberculosis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Tuberculosis Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Tuberculosis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Tuberculosis Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Tuberculosis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Tuberculosis Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Human Tuberculosis Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Human Tuberculosis Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Human Tuberculosis Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Tuberculosis Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Human Tuberculosis Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Human Tuberculosis Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Human Tuberculosis Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Human Tuberculosis Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Human Tuberculosis Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Human Tuberculosis Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Human Tuberculosis Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Tuberculosis Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Tuberculosis Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Human Tuberculosis Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Human Tuberculosis Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Human Tuberculosis Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. GlaxoSmithKline Human Tuberculosis Vaccine Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Merck Human Tuberculosis Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Serum Institute of India Human Tuberculosis Vaccine Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. Valneva Corporation Information
Table 86. Valneva Description and Business Overview
Table 87. Valneva Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Valneva Human Tuberculosis Vaccine Product
Table 89. Valneva Recent Developments/Updates
Table 90. Archivel Farma Corporation Information
Table 91. Archivel Farma Description and Business Overview
Table 92. Archivel Farma Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Archivel Farma Human Tuberculosis Vaccine Product
Table 94. Archivel Farma Recent Developments/Updates
Table 95. BIOFABRI (Zendal) Corporation Information
Table 96. BIOFABRI (Zendal) Description and Business Overview
Table 97. BIOFABRI (Zendal) Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. BIOFABRI (Zendal) Human Tuberculosis Vaccine Product
Table 99. BIOFABRI (Zendal) Recent Developments/Updates
Table 100. Japan BCG Laboratory Corporation Information
Table 101. Japan BCG Laboratory Description and Business Overview
Table 102. Japan BCG Laboratory Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Japan BCG Laboratory Human Tuberculosis Vaccine Product
Table 104. Japan BCG Laboratory Recent Developments/Updates
Table 105. GreenSignal Bio Pharma Corporation Information
Table 106. GreenSignal Bio Pharma Description and Business Overview
Table 107. GreenSignal Bio Pharma Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. GreenSignal Bio Pharma Human Tuberculosis Vaccine Product
Table 109. GreenSignal Bio Pharma Recent Developments/Updates
Table 110. AJ Vaccines Corporation Information
Table 111. AJ Vaccines Description and Business Overview
Table 112. AJ Vaccines Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. AJ Vaccines Human Tuberculosis Vaccine Product
Table 114. AJ Vaccines Recent Developments/Updates
Table 115. Taj Pharma India Corporation Information
Table 116. Taj Pharma India Description and Business Overview
Table 117. Taj Pharma India Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Taj Pharma India Human Tuberculosis Vaccine Product
Table 119. Taj Pharma India Recent Developments/Updates
Table 120. Biomed Lublin Corporation Information
Table 121. Biomed Lublin Description and Business Overview
Table 122. Biomed Lublin Human Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Biomed Lublin Human Tuberculosis Vaccine Product
Table 124. Biomed Lublin Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Human Tuberculosis Vaccine Distributors List
Table 128. Human Tuberculosis Vaccine Customers List
Table 129. Human Tuberculosis Vaccine Market Trends
Table 130. Human Tuberculosis Vaccine Market Drivers
Table 131. Human Tuberculosis Vaccine Market Challenges
Table 132. Human Tuberculosis Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Human Tuberculosis Vaccine
Figure 2. Global Human Tuberculosis Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Human Tuberculosis Vaccine Market Share by Type in 2022 & 2029
Figure 4. Intradermal Product Picture
Figure 5. Percutaneous Product Picture
Figure 6. Global Human Tuberculosis Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Human Tuberculosis Vaccine Market Share by Application in 2022 & 2029
Figure 8. Pediatrics
Figure 9. Adults
Figure 10. Global Human Tuberculosis Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Human Tuberculosis Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Human Tuberculosis Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Human Tuberculosis Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Human Tuberculosis Vaccine Report Years Considered
Figure 15. Human Tuberculosis Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Human Tuberculosis Vaccine Players: Market Share by Revenue in 2022
Figure 18. Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Human Tuberculosis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Human Tuberculosis Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Human Tuberculosis Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Human Tuberculosis Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Human Tuberculosis Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Human Tuberculosis Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Human Tuberculosis Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Human Tuberculosis Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Human Tuberculosis Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Human Tuberculosis Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Human Tuberculosis Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Human Tuberculosis Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Human Tuberculosis Vaccine by Type (2018-2029)
Figure 54. Global Human Tuberculosis Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Human Tuberculosis Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Human Tuberculosis Vaccine by Application (2018-2029)
Figure 57. Global Human Tuberculosis Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. Human Tuberculosis Vaccine Value Chain
Figure 59. Human Tuberculosis Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Human Tuberculosis Vaccine
Figure 2. Global Human Tuberculosis Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Human Tuberculosis Vaccine Market Share by Type in 2022 & 2029
Figure 4. Intradermal Product Picture
Figure 5. Percutaneous Product Picture
Figure 6. Global Human Tuberculosis Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Human Tuberculosis Vaccine Market Share by Application in 2022 & 2029
Figure 8. Pediatrics
Figure 9. Adults
Figure 10. Global Human Tuberculosis Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Human Tuberculosis Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Human Tuberculosis Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Human Tuberculosis Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Human Tuberculosis Vaccine Report Years Considered
Figure 15. Human Tuberculosis Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Human Tuberculosis Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Human Tuberculosis Vaccine Players: Market Share by Revenue in 2022
Figure 18. Human Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Human Tuberculosis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Human Tuberculosis Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Human Tuberculosis Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Human Tuberculosis Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Human Tuberculosis Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Human Tuberculosis Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Human Tuberculosis Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Human Tuberculosis Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Human Tuberculosis Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Human Tuberculosis Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Human Tuberculosis Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Human Tuberculosis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Human Tuberculosis Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Human Tuberculosis Vaccine by Type (2018-2029)
Figure 54. Global Human Tuberculosis Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Human Tuberculosis Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Human Tuberculosis Vaccine by Application (2018-2029)
Figure 57. Global Human Tuberculosis Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. Human Tuberculosis Vaccine Value Chain
Figure 59. Human Tuberculosis Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
